Diligence memo · auto-generated · as of July 3, 2026

Balance Ophthalmics, Inc.

Balance Ophthalmics, Inc. looks fair against its niche peers and is quiet on financing cadence.

SourceRaising on rhythm with a 1.8× step-up on the last round — momentum worth tracking before it's priced in.

Businessfiled

Balance Ophthalmics, Inc. operates in Other Health Care, based in SIOUX FALLS.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Balance Ophthalmics, Inc. has raised $5.7M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).

Largest single filing: $3.7M on 2024-09-20.

Most recent recorded round closed around 2024-09-20.

Valuation (modeled)modeled

Provath models Balance Ophthalmics, Inc. at approximately $15M (range $3.1M–$37M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.24× the median modeled value of Seed Other Health Care companies in 2022–2024 (244 peers) — value vs value, same stage and era. Within the normal band (124% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 14 months.

Last raise 21 mo ago; this sector typically re-raises about every 14 months.

Slightly overdue versus sector cadence.

The last round stepped up 1.8× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 67% of Other Health Care peers (5377 compared).

Modeled value ranks above 41% of those peers.

Closest niche peers: Elmntri LLC, Atreo, Inc., descendantsDNA, Inc., Westover Project Investor LLC, Dentulu Inc.

Peoplefiled

6 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.